RUA Life Sciences (LON:RUA) Announces Quarterly Earnings Results

RUA Life Sciences (LON:RUA) released its earnings results on Tuesday. The company reported GBX (0.33) earnings per share for the quarter, Digital Look Earnings reports. RUA Life Sciences had a negative net margin of 3.26% and a negative return on equity of 2.03%.

RUA Life Sciences Trading Down 4.2%

Shares of RUA stock opened at GBX 18.20 on Friday. The company has a debt-to-equity ratio of 18.95, a quick ratio of 7.32 and a current ratio of 4.64. The stock has a market capitalization of £11.29 million, a P/E ratio of -2.61 and a beta of 0.96. The company has a 50 day moving average price of GBX 19.96 and a 200 day moving average price of GBX 16. RUA Life Sciences has a fifty-two week low of GBX 10.42 and a fifty-two week high of GBX 26.80.

RUA Life Sciences Company Profile

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.